IL85112A0 - Method for blood cell separation - Google Patents

Method for blood cell separation

Info

Publication number
IL85112A0
IL85112A0 IL85112A IL8511288A IL85112A0 IL 85112 A0 IL85112 A0 IL 85112A0 IL 85112 A IL85112 A IL 85112A IL 8511288 A IL8511288 A IL 8511288A IL 85112 A0 IL85112 A0 IL 85112A0
Authority
IL
Israel
Prior art keywords
blood cell
cell separation
blood cells
white blood
red
Prior art date
Application number
IL85112A
Other languages
English (en)
Original Assignee
Interferon Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Interferon Sciences Inc filed Critical Interferon Sciences Inc
Publication of IL85112A0 publication Critical patent/IL85112A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/56—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3693—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3693—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging
    • A61M1/3695—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits using separation based on different densities of components, e.g. centrifuging with sedimentation by gravity
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • External Artificial Organs (AREA)
IL85112A 1987-01-16 1988-01-15 Method for blood cell separation IL85112A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/003,838 US4744907A (en) 1987-01-16 1987-01-16 Blood cell separation

Publications (1)

Publication Number Publication Date
IL85112A0 true IL85112A0 (en) 1988-06-30

Family

ID=21707830

Family Applications (1)

Application Number Title Priority Date Filing Date
IL85112A IL85112A0 (en) 1987-01-16 1988-01-15 Method for blood cell separation

Country Status (11)

Country Link
US (1) US4744907A (fr)
EP (1) EP0276931B1 (fr)
JP (1) JPH02501890A (fr)
CN (1) CN88101007A (fr)
AT (1) ATE73665T1 (fr)
AU (1) AU1189888A (fr)
CA (1) CA1299104C (fr)
DE (1) DE3869146D1 (fr)
IL (1) IL85112A0 (fr)
NZ (1) NZ223221A (fr)
WO (1) WO1988005331A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6676967B1 (en) * 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US7169547B2 (en) 1994-12-05 2007-01-30 New York Blood Center, Inc. High concentration white blood cells as a therapeutic product
US5789147A (en) * 1994-12-05 1998-08-04 New York Blood Center, Inc. Method for concentrating white cells from whole blood by adding a red cell sedimentation reagent to whole anticoagulated blood
AU5309396A (en) * 1995-04-13 1996-10-30 Travenol Laboratories (Israel) Ltd. Leukocyte filtration method and apparatus
US8304185B2 (en) 2009-07-17 2012-11-06 Canon U.S. Life Sciences, Inc. Methods and systems for DNA isolation on a microfluidic device
JP5795255B2 (ja) 2008-07-18 2015-10-14 キヤノン ユー．エス． ライフ サイエンシズ， インコーポレイテッドＣａｎｏｎ Ｕ．Ｓ． Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ， Ｉｎｃ． 微小流体ｄｎａ試料調製のための方法およびシステム
CN101971796B (zh) * 2010-05-26 2013-04-17 赛业（广州）生物科技有限公司 无蛋白非程序细胞冻存液
US20160130553A1 (en) 2014-05-15 2016-05-12 Kellbenx Incorporated PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING
US12202890B1 (en) 2014-11-07 2025-01-21 Kellbenx Incorporated Antibodies for detection and enrichment of fetal cells and their use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA559303A (fr) * 1958-06-24 E. Gloor Walter Clarification de liquide avec coagulation
US3338828A (en) * 1964-07-29 1967-08-29 Joseph R Clark Purification of water supplies and aqueous wastes
DE1617401A1 (de) * 1966-05-02 1972-02-17 Centre Nat Rech Scient Verfahren zur Herstellung von Interferon-Praeparaten
US4004975A (en) * 1975-12-30 1977-01-25 The United States Of America As Represented By The Secretary Of The Navy Method of isolating and cryopreserving human white cells from whole blood
AU524397B2 (en) * 1978-12-13 1982-09-16 Antonio Ferrante Medium for separation of human blood leukocytes
US4255256A (en) * 1978-12-13 1981-03-10 Antonio Ferrante Medium for the separation of human blood leucocytes
DE3009126A1 (de) * 1980-03-10 1981-10-08 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur gewinnung von funktionell und morphologisch intakten und lebensfaehigen leukozyten aus blut
US4487700A (en) * 1983-02-18 1984-12-11 Technicon Instruments Corporation Method and apparatus for separating lymphocytes from anticoagulated blood
GB8411192D0 (en) * 1984-05-02 1984-06-06 Celltech Ltd Separating animal cells from liquid culture

Also Published As

Publication number Publication date
ATE73665T1 (de) 1992-04-15
CA1299104C (fr) 1992-04-21
CN88101007A (zh) 1988-09-07
NZ223221A (en) 1989-06-28
EP0276931A1 (fr) 1988-08-03
WO1988005331A1 (fr) 1988-07-28
US4744907A (en) 1988-05-17
EP0276931B1 (fr) 1992-03-18
DE3869146D1 (de) 1992-04-23
JPH02501890A (ja) 1990-06-28
AU1189888A (en) 1988-08-10

Similar Documents

Publication Publication Date Title
DE3479057D1 (en) Fluorescent multiparameter particle analysis
PT78028A (en) Process for the preparation of n-vinyl-lactames based polymers useful in the recovery and processing of natural resources
AU1189888A (en) Blood cell separation
ATE195148T1 (de) Prozess zur rekombinanten herstellung von hiv-2 - proteinen sowie zellen, die hiv-2 - proteine exprimiert
IL86177A0 (en) Simplified method for the preparation of human lymphokine activated killer cells
GB2163555B (en) Apparatus and process for determining the deformability of the red corpuscles in the blood
EP0240824A3 (en) Cell separator and process of producing the same
GR80199B (en) Assay kit for detection of antibodies in human serum and method of producing same
SG56792G (en) Methods and apparatus for analysis of particles and cells
EP0133329A3 (en) Method and reagent for the determination of alpha-amylase
GB2141357B (en) Method for making irregular shaped single crystal particles and the use therof in anodes for electrochemical cells
DE3764981D1 (de) Gefrorene hefe in form von frei fliessenden teilchen, verfahren zu deren herstellung und verwendung dieser hefen in gefrorenen teigen.
FI843947A7 (fi) Menetelmä ja laite hylättävien aineosien käsittelemiseksi sykloneissa ja muissa erotinlaitteissa.
AU7913887A (en) Method for the removal of undesired cells from human lymphocyte populations, application of the method in monoclonal antibody production and kit therefor
EP0130946A3 (en) Process for the separation of flour containing polysaccharide into fractions rich in proteins and poor in proteins
GR3036052T3 (en) Process for the biochemical oxidation of steroids and genetically engineered cells to be used therefor.
NZ220765A (en) Method of fusing two mammalian cells
AU574971B2 (en) Cell separation
IL73181A0 (en) Process for the preparation of carrier-bound fibrin and its use in a process for the determination of proteins
FI953141L (fi) Menetelmä soluissa tuotettavan HIV:n glykoproteiinin GP 160 eristämiseksi ja puhdistamiseksi
AU2910589A (en) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in the method
GR862046B (en) Method for the processing and enrichment of hunditis ore which is found in the area of kozani-servia and its uses
AU7686387A (en) The recycling of fluoride in coal refining
JO1455B1 (en) A process for installing a new Benzo Eoxipan and its uses in medical treatment
JPS6486872A (en) Method for separating glycan hydrolase